Atossa Therapeutics Inc (ATOS) is lower by Wednesday morning, with the stock falling -1.20% in pre-market trading to 2.47. ATOS's short-term technical score of 46 indicates that the stock has traded less bullishly over the last month than 54% of stocks on the market. In the Biotechnology industry, which ranks 137 out of 146 industries, Atossa Therapeutics Inc ranks higher than 79% of stocks. Atossa Therapeutics Inc has fallen 12.59% over the past month, closing at $2.91 on October 20. During this period of time, the stock fell as low as $2.50 and as high as $2.98. ATOS has an average analyst recommendation of Strong Buy. The company has an average price target of $7.00.
ATOS has an Overall Score of 50. Find out what this means to you and get the rest of the rankings on ATOS!